426 related articles for article (PubMed ID: 18490838)
1. Bilateral primary adrenal non-Hodgkin's lymphoma and primary adrenocortical carcinoma--review of the literature preoperative differentiation of adrenal tumors.
Ozimek A; Diebold J; Linke R; Heyn J; Hallfeldt K; Mussack T
Endocr J; 2008 Aug; 55(4):625-38. PubMed ID: 18490838
[TBL] [Abstract][Full Text] [Related]
2. Rare adrenal tumors in children.
Mihai R
Semin Pediatr Surg; 2014 Apr; 23(2):71-5. PubMed ID: 24931351
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinoma: Retrospective analysis of the last 22 years.
Guelho D; Paiva I; Vieira A; Carrilho F
Endocrinol Nutr; 2016 May; 63(5):212-9. PubMed ID: 26969077
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
Berruti A; Grisanti S; Pulzer A; Claps M; Daffara F; Loli P; Mannelli M; Boscaro M; Arvat E; Tiberio G; Hahner S; Zaggia B; Porpiglia F; Volante M; Fassnacht M; Terzolo M
J Clin Endocrinol Metab; 2017 Apr; 102(4):1358-1365. PubMed ID: 28324035
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of adrenocortical carcinoma.
Ranvier GG; Inabnet WB
Endocrinol Metab Clin North Am; 2015 Jun; 44(2):435-52. PubMed ID: 26038210
[TBL] [Abstract][Full Text] [Related]
6. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
7. Risk of adrenocortical carcinoma in adrenal tumours greater than 8 cm.
Abdel-Aziz TE; Rajeev P; Sadler G; Weaver A; Mihai R
World J Surg; 2015 May; 39(5):1268-73. PubMed ID: 25526921
[TBL] [Abstract][Full Text] [Related]
8. Update in adrenocortical carcinoma.
Fassnacht M; Kroiss M; Allolio B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
[TBL] [Abstract][Full Text] [Related]
9. New perspectives for mitotane treatment of adrenocortical carcinoma.
Puglisi S; Calabrese A; Basile V; Pia A; Reimondo G; Perotti P; Terzolo M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101415. PubMed ID: 32179008
[TBL] [Abstract][Full Text] [Related]
10. Management of endocrine manifestations and the use of mitotane as a chemotherapeutic agent for adrenocortical carcinoma.
Veytsman I; Nieman L; Fojo T
J Clin Oncol; 2009 Sep; 27(27):4619-29. PubMed ID: 19667279
[TBL] [Abstract][Full Text] [Related]
11. Mitotane treatment for adrenocortical carcinoma: an overview.
De Francia S; Ardito A; Daffara F; Zaggia B; Germano A; Berruti A; Di Carlo F
Minerva Endocrinol; 2012 Mar; 37(1):9-23. PubMed ID: 22382612
[TBL] [Abstract][Full Text] [Related]
12. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane.
Wängberg B; Khorram-Manesh A; Jansson S; Nilsson B; Nilsson O; Jakobsson CE; Lindstedt S; Odén A; Ahlman H
Endocr Relat Cancer; 2010 Mar; 17(1):265-72. PubMed ID: 20026647
[TBL] [Abstract][Full Text] [Related]
13. Predicitve Value of FDG Uptake in the Remaining Adrenal Gland Following Adrenalectomy for Adrenocortical Cancer.
Loewe R; Rogowski-Lehmann N; Pfluger T; Reincke M; Hahner S; Bluemel C; Fassnacht M; Beuschlein F
Horm Metab Res; 2021 Jan; 53(1):24-31. PubMed ID: 33086388
[TBL] [Abstract][Full Text] [Related]
14. Giant nonfunctioning adrenal tumors: two case reports and review of the literature.
Chatzoulis G; Passos I; Bakaloudi DR; Giannakidis D; Koumpoulas A; Ioannidis K; Tsifountoudis I; Pappas D; Spyridopoulos P
J Med Case Rep; 2018 Nov; 12(1):335. PubMed ID: 30413177
[TBL] [Abstract][Full Text] [Related]
15. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.
Bednarski BK; Habra MA; Phan A; Milton DR; Wood C; Vauthey N; Evans DB; Katz MH; Ng CS; Perrier ND; Lee JE; Grubbs EG
World J Surg; 2014 Jun; 38(6):1318-27. PubMed ID: 24615603
[TBL] [Abstract][Full Text] [Related]
16. Oncocytic adrenocortical carcinoma: a rare adrenal tumor subtype.
Sumner E; Acar BC; Acker MR
Can J Urol; 2017 Jun; 24(3):8865-8867. PubMed ID: 28646944
[TBL] [Abstract][Full Text] [Related]
17. The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis.
Mochizuki T; Kawahara T; Takamoto D; Makiyama K; Hattori Y; Teranishi JI; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2017 Jun; 17(1):49. PubMed ID: 28662713
[TBL] [Abstract][Full Text] [Related]
18. An Interesting Case of Hepatic Adrenocortical Carcinoma.
Permana H; Darmawan G; Ritonga E; Kusumawati M; Miftahurachman M; Soetedjo NN
Acta Med Indones; 2018 Jul; 50(3):257-259. PubMed ID: 30333277
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Adrenocortical Carcinoma Successfully Treated with Multimodal Therapy].
Bando S; Ishii G; Yamada H; Kimura T; Furuta N; Egawa S
Hinyokika Kiyo; 2016 Jan; 62(1):15-9. PubMed ID: 26932330
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive adrenal surgery: virtue or vice?
Winoker JS; Ahlborn DT; Omidele OO; Fernandez-Ranvier G; Derweesh IH; Mehrazin R
Future Oncol; 2018 Feb; 14(3):267-276. PubMed ID: 29345155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
